New discovery could make AIDS vaccine possible
Good news about to all those who are suffering with AIDS. The analysis of the new found antibodies are in its early stages, yet its great potential seems evident.
These are not like other types of antibodies; molecules created by the immune system to seek out, neutralize and help kill specific invaders. The bNAbs can block infection from many kinds of HIV.
Scientists at The Scripps Research Institute in La Jolla have helped identify two rare and potent human antibodies against HIV, the virus that causes AIDS.
Their discovery could finally reveal a chink in the armor of the deadly virus and lead to development of an effective, broad-based AIDS vaccine.
The research will be published in today's edition of the journal Science. The Scripps team worked with those from the International AIDS Vaccine Initiative and biotechnology companies Theraclone Sciences in Seattle and Monogram Biosciences in San Francisco.
Before this latest announcement, only five of these pathogen-busting proteins — called broadly neutralizing antibodies, or bNAbs — had been pinpointed in people. The last finding came more than a decade ago.